Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tomoko Hisai"'
Autor:
Takanori Takebe, Keisuke Sekine, Masaki Kimura, Emi Yoshizawa, Satoru Ayano, Masaru Koido, Shizuka Funayama, Noriko Nakanishi, Tomoko Hisai, Tatsuya Kobayashi, Toshiharu Kasai, Rina Kitada, Akira Mori, Hiroaki Ayabe, Yoko Ejiri, Naoki Amimoto, Yosuke Yamazaki, Shimpei Ogawa, Momotaro Ishikawa, Yasujiro Kiyota, Yasuhiko Sato, Kohei Nozawa, Satoshi Okamoto, Yasuharu Ueno, Hideki Taniguchi
Publikováno v:
Cell Reports, Vol 21, Iss 10, Pp 2661-2670 (2017)
Summary: Organoid technology provides a revolutionary paradigm toward therapy but has yet to be applied in humans, mainly because of reproducibility and scalability challenges. Here, we overcome these limitations by evolving a scalable organ bud prod
Externí odkaz:
https://doaj.org/article/a82cbaeac6e0480a92f03b989a1e317e
Autor:
Kengo Saba, Ryosuke Kurashina, Tomoko Hisai, Tatsuro Irimura, Kaori Denda-Nagai, Hiromitsu Hara
Publikováno v:
Glycobiology
Ligand-induced cellular signaling involved in interleukin 10 (IL-10) production by lamina propria macrophages (LPMs) during their interactions with commensal bacteria is not clearly understood. We previously showed, using mice lacking a C-type lectin
Autor:
Shimpei Ogawa, Yasuhiko Sato, Hiroaki Ayabe, Masaru Koido, Akira Mori, Emi Yoshizawa, Yoko Ejiri, Keisuke Sekine, Shizuka Funayama, Kohei Nozawa, Momotaro Ishikawa, Tatsuya Kobayashi, Toshiharu Kasai, Rina Kitada, Satoshi Okamoto, Noriko Nakanishi, Tomoko Hisai, Yasujiro Kiyota, Yosuke Yamazaki, Masaki Kimura, Satoru Ayano, Takanori Takebe, Naoki Amimoto, Yasuharu Ueno, Hideki Taniguchi
Publikováno v:
Cell Reports, Vol 21, Iss 10, Pp 2661-2670 (2017)
Summary: Organoid technology provides a revolutionary paradigm toward therapy but has yet to be applied in humans, mainly because of reproducibility and scalability challenges. Here, we overcome these limitations by evolving a scalable organ bud prod
Autor:
Mahendra S. Rao, Thelma Y. Garcia, Ying Pei, Tomoko Hisai, Shereen Chew, Xianmin Zeng, Toshiharu Kasai, Hideki Taniguchi, Takanori Takebe, Deepak A. Lamba
Publikováno v:
Cytotherapy. 20(6)
Background aims We have previously reported the generation of a current Good Manufacture Practice (cGMP)-compliant induced pluripotent stem cell (iPSC) line for clinical applications. Here we show that multiple cellular products currently being consi